A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis (PAR)

PHASE4CompletedINTERVENTIONAL
Enrollment

737

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Perennial Allergic Rhinitis
Interventions
DRUG

ciclesonide nasal aerosol

ciclesonide nasal aerosol 74 mcg (given as 1 actuation per nostril of 37 mcg ciclesonide nasal aerosol)

DRUG

ciclesonide nasal spray

ciclesonide nasal spray 200 mcg (given as 2 actuations per nostril of 50 mcg ciclesonide nasal spray)

Trial Locations (31)

18020

Valley Clinical Research Center, Bethlehem

19013

Asthma and Allergy Research Associates, Upland

20814

Gordon D Raphael, MD, Bethesda

27262

Allergy and Asthma Center of NC, PA, High Point

27607

North Carolina Clinical Research, Raleigh

29406

National Allergy, Asthma & Uticaria Centers of Charleston, P.A., Charleston

30046

DataQuest Medical Research LLC, Lawerenceville

30047

Asthma & Allergy Consultants, PC, Lilburn

48197

Respiratory Medicine Research Institute of Michigan, PLC, Ypsilanti

55402

Clinical Research Institute Inc., Minneappolis

59718

Clinical Research Group of Montanta, Bozeman

63141

The Clinical Research Center, LLC, St Louis

75231

Pharmaceutical Research and Consulting Inc., Dallas

78028

Kerrville Research Associates, PA, Kerrville

78130

Central Texas Health Research, New Braunfels

78229

Biogenics Research Institute, San Antonio

Sylvana Research Associates, San Antonio

78731

Isis Clinical Research, LLC, Austin

78759

Sirius Clinical Research LLC, Austin

80907

Storms Clinical Research Institute, Colorado Springs

92120

Allergy Associates Medical Group Inc., San Diego

92691

Allergy & Asthma Associates of Southern California, Mission Viejo

92868

CHOC PSF AMC - Division of Allergy, Asthma and Immunology, Orange

95207

Bensch Research Associates, Stockton

97202

Allergy Assocaites Research Center, Portland

98115

ASTHMA Inc. Clinical Research Center, Seattle

01440

Medical Education and Research Management Services of New England, Gardner

02747

Northeast Medical Research Associates, Inc., North Dartmouth

08724

Ocean Allergy & Respiratory Research Center, Brick

07721

Atlantic Research Center, LLC, Ocean City

08558

Princeton Center for Clinical Research, Skillman

All Listed Sponsors
lead

Sumitomo Pharma America, Inc.

INDUSTRY

NCT01654536 - A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis (PAR) | Biotech Hunter | Biotech Hunter